Indeed - in recent interviews SI stated that MSB wants to partner with other companies regarding back pain and heart failure treatments. The world market for these two 'blockbusters' is just too large to not involve established pharma.
I'm ok with that: major partners = increased manufacturing scale = lower unit cost = more patients successfully treated/greater revenue.
- Forums
- ASX - By Stock
- MSB
- Ann: MSB Wins Fierce Biotech Innovation Award for Remestemcel-L
Ann: MSB Wins Fierce Biotech Innovation Award for Remestemcel-L, page-211
-
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
97.0¢ |
Change
-0.025(2.51%) |
Mkt cap ! $1.107B |
Open | High | Low | Value | Volume |
97.0¢ | $1.01 | 96.5¢ | $7.757M | 7.884M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 274918 | 97.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.5¢ | 974 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 274918 | 0.970 |
7 | 85827 | 0.965 |
14 | 252006 | 0.960 |
3 | 67909 | 0.955 |
25 | 222534 | 0.950 |
Price($) | Vol. | No. |
---|---|---|
0.975 | 974 | 1 |
0.980 | 45619 | 1 |
0.990 | 50389 | 3 |
0.995 | 45574 | 3 |
1.000 | 127030 | 3 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |